Loading
Albany Molecular Research Inc has a thin disclosure history in our data (latest filing: 8 February 2016). New filings will appear here as soon as they are published. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
FY ended December 2016 · cache
23 of 23 declarations
Albany Molecular Research Inc is a company focused on the research and development of pharmaceutical solutions. It operates on the XNAS market.
Purchases our model currently ranks for the recommendations list.
All recommendations